| Literature DB >> 35956951 |
Wei Liu1, Wenning Yang1, Xueyan Li1, Dongying Qi1, Hongjiao Chen1, Huining Liu1, Shuang Yu1, Guopeng Wang2, Yang Liu1.
Abstract
(1)Entities:
Keywords: bioactive peptides; bioavailability; ginger protease; peptides identification
Mesh:
Substances:
Year: 2022 PMID: 35956951 PMCID: PMC9370692 DOI: 10.3390/molecules27155001
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.927
Figure 1Flowchart of the study design.
Figure 2DH and DPPH radical scavenging activity of hydrolysates prepared by different proteases. Data were presented as mean ± SD (n = 3). Bar graphs followed by different letters indicate significant differences (p < 0.05) (ANOVA/Dunnet’s test). DH: degree of hydrolysis. DPPH: 2,2-diphenyl-1-picrylhydrazyl.
Figure 3The concentration of total Hyp in rat plasma after oral ingestion (2.4 g/kg). Symbols: gelatin (■), HP (▲), HA (▼), HB (◆), GDCH (●). Data were shown as mean ± SD, n = 6. HA: alkaline protease hydrolysate; HP: pepsin hydrolysate; HB: bromelain hydrolysate; GDCH: ginger protease-degraded collagen hydrolysate.
Pharmacokinetic parameters of the total Hyp in rat plasma after ingestion of gelatin and hydrolysates (HA, HB, HP, and GDCH).
| Parameter | Gelatin | HP | HA | HB | GDCH |
|---|---|---|---|---|---|
| AUC0–8 h (h µg mL−1) | 100.65 ± 14.68 c | 118.72 ± 12.40 c | 188.29 ± 18.39 b | 191.86 ± 16.91 b | 355.01 ± 22.08 a |
| Cmax (µg mL−1) | 27.44 ± 8.40 c | 31.89 ± 10.48 c | 51.82 ± 4.64 b | 52.54 ± 14.29 b | 71.24 ± 8.61 a |
| Tmax (h) | 2.00 ± 0.00 a | 2.00 ± 0.00 a | 1.83 ± 0.41 a | 1.83 ± 0.41 a | 1.67 ± 0.52 a |
Results were shown as the mean ± SD from six independent samples (n = 6). Values followed by different superscript letters are significantly different at p < 0.05 (ANOVA/Dunnet’s test). HA: alkaline protease hydrolysate; HP: pepsin hydrolysate; HB: bromelain hydrolysate; GDCH: ginger protease-degraded collagen hydrolysate.
The molecular weight distribution of the GDCH.
| Molecular Weight Range/Da | Percentage of Peak Area/% |
|---|---|
| >10,000 | 0.11 |
| 5000–10,000 | 1.15 |
| 3000–5000 | 4.32 |
| 2000–3000 | 6.05 |
| 1000–2000 | 15.51 |
| 576–1000 | 26.45 |
| 189–576 | 42.19 |
| <189 | 4.22 |
The dipeptides and tripeptides in the GDCH.
| Type | Peptide | tR/min | Formula | [M + H]+ | Error/10−6 | MS/MS Fragments ( | |
|---|---|---|---|---|---|---|---|
| Tripeptides | Gly-Pro-Y | Gly-Pro-Ala | 3.2 | C10H17N3O4 | 244.1291 | 0.410 | 70.0658, 127.0866, 155.0813, 187.1075 |
| Gly-Pro-Val | 8.22 | C12H21N3O4 | 272.1602 | 1.102 | 70.0658, 127.0866, 155.0813, 215.1388 | ||
| Gly-Pro-Gln | 2.07 | C12H20N4O5 | 301.1510 | −1.328 | 70.0658, 127.0866, 155.0813, 244.1289 | ||
| Gly-Pro-Glu | 3.75 | C12H19N3O6 | 302.1342 | 1.655 | 70.0658, 127.0866, 155.0813, 245.1128 | ||
| Gly-Pro-Arg | 1.93 | C13H24N6O4 | 329.1929 | 0.608 | 70.0658, 127.0866, 175.1188 | ||
| Z-Pro-Gly | Ala-Pro-Gly | 3.41 | C10H17N3O4 | 244.1288 | 1.638 | 70.0658, 173.0910 | |
| Leu-Pro-Gly | 8.84 | C13H23N3O4 | 286.1757 | 1.398 | 70.0658, 86.0969, 173.0919, 211.1438 | ||
| X-Hyp-Gly | Leu/Ile-Hyp-Gly | 8.14 | C13H23N3O5 | 302.1708 | 0.662 | 86.0605, 189.0868 | |
| Phe-Hyp-Gly | 7.95 | C13H23N3O5 | 336.1551 | 0.892 | 86.0605, 120.0869, 189.0868 | ||
| Dipeptides | Hyp-Gly | 8.75 | C16H21N3O5 | 189.0869 | 0.000 | 86.0606 | |
| Tetrapeptides | Gly-Pro-Hyp-Gly | 1.31 | C7H12N2O4 | 343.1615 | −0.874 | 70.0658, 127.0866, 155.0813, 189.0867 | |
The dipeptides and tripeptides in rat plasma after oral ingestion of GDCH.
| Peptide | tR/min | Formula | [M + H]+ | Error/10−6 | MS/MS Fragments ( |
|---|---|---|---|---|---|
| Pro-Hyp | 1.61 | C10H16N2O4 | 229.1182 | −0.873 | 70.0658, 132.0654 |
| Gly-Pro-Hyp | 2.82 | C12H19N3O5 | 286.1397 | −2.446 | 70.0658, 127.0866, 155.0813 |
| Pro-Hyp-Gly | 1.87 | C12H19N3O5 | 286.1397 | −1.048 | 70.0658, 86.0605, 189.0869 |
| Leu/Ile-Hyp-Gly | 8.14 | C13H23N3O5 | 302.1708 | 0.662 | 86.0605, 189.0868 |
| Phe-Hyp-Gly | 7.95 | C13H23N3O5 | 336.1551 | 0.892 | 86.0605, 120.0869, 189.0868 |
The potential bioactive peptides obtained based on Peptide Ranker (>0.80) and ToxinPred Website.
| No. | Peptides | Peptide Ranker Score | Formula | Mass/Da | Length | Toxicity |
|---|---|---|---|---|---|---|
| 1 | GPPGPPGPGP | 0.948 | 828.413 | C38 H56 N10 O11 | 10 | no toxicity |
| 2 | GPXGPPGPGP | 0.948 | 844.403 | C38 H56 N10 O12 | 10 | no toxicity |
| 3 | GPXGPXGPGP | 0.948 | 860.3929 | C38 H56 N10 O13 | 10 | no toxicity |
| 4 | GPSGPXGPXGPXG | 0.939 | 1117.4891 | C48 H71 N13 O18 | 13 | no toxicity |
| 5 | GPSGFXGPK | 0.937 | 858.4186 | C39 H58 N10 O12 | 9 | no toxicity |
| 6 | PGXGGPXGPXG | 0.935 | 933.4044 | C40 H59 N11 O15 | 11 | no toxicity |
| 7 | GPXGLXGPXGPA | 0.924 | 1060.5042 | C47 H72 N12 O16 | 12 | no toxicity |
| 8 | GPXGLXGPPGPA | 0.924 | 1044.5142 | C47 H72 N12 O15 | 12 | no toxicity |
| 9 | GPPVPGPIGP | 0.900 | 886.4912 | C42 H66 N10 O11 | 10 | no toxicity |
| 10 | GPXGLXGPPGTP | 0.893 | 1074.5247 | C48 H74 N12 O16 | 12 | no toxicity |
| 11 | SGPPVPGPIGP | 0.890 | 973.5233 | C45 H71 N11 O13 | 11 | no toxicity |
| 12 | KAPDPFR | 0.872 | 829.4446 | C38 H59 N11 O10 | 7 | no toxicity |
| 13 | GPPGPXGEEGKRGAR | 0.869 | 1476.7384 | C61 H100 N22 O21 | 15 | no toxicity |
| 14 | GPXGPXGEEGKRGAR | 0.869 | 1492.7284 | C61 H100 N22 O22 | 15 | no toxicity |
| 15 | GXAGNAGPXGPXGPA | 0.867 | 1260.5587 | C53 H80 N16 O20 | 15 | no toxicity |
| 16 | G(+42.01)PAGNAGPXGPXGPA | 0.867 | 1286.5792 | C55 H82 N16 O20 | 15 | no toxicity |
| 17 | GPXGPXGEEGKRGARGEXG | 0.860 | 1848.8566 | C75 H120 N26 O29 | 19 | no toxicity |
| 18 | GPXGERGFXG | 0.857 | 1001.4468 | C43 H63 N13 O15 | 10 | no toxicity |
| 19 | GXPGERGFXG | 0.857 | 1001.4468 | C43 H63 N13 O15 | 10 | no toxicity |
| 20 | AGPXGPXGEKGSPG | 0.857 | 1235.5684 | C52 H81 N15 O20 | 14 | no toxicity |
| 21 | GNAGPXGPXGPA | 0.856 | 1019.4573 | C43 H65 N13 O16 | 12 | no toxicity |
| 22 | GPXGPXGEKGSPG | 0.843 | 1164.5312 | C49 H76 N14 O19 | 13 | no toxicity |
| 23 | XAGNAGPXGPXGPA | 0.843 | 1203.5372 | C51 H77 N15 O19 | 14 | no toxicity |
| 24 | GGXGERGAXGGRGFXG | 0.836 | 1472.6609 | C60 H92 N22 O22 | 16 | no toxicity |
| 25 | AAGPXGPXGEKGSPG | 0.826 | 1306.6055 | C55 H86 N16 O21 | 15 | no toxicity |
| 26 | NAGPXGPXGPA | 0.826 | 962.4359 | C41 H62 N12 O15 | 11 | no toxicity |
| 27 | XGIGFPGPT | 0.806 | 857.4233 | C40 H59 N9 O12 | 9 | no toxicity |
| 28 | GPPXGIVGPXGPA | 0.801 | 1046.5298 | C47 H74 N12 O15 | 12 | no toxicity |
X: hydroxyproline.
Amino acids at P2 position.
| Amino Acid | Total Number of Peptides | Percentage (%) |
|---|---|---|
| Pro | 91 | 66.91 |
| Hyp | 20 | 14.71 |
| Ala | 13 | 9.56 |
| Gly | 5 | 3.68 |
| Leu | 2 | 1.47 |
| Val | 1 | 0.74 |
| Phe | 1 | 0.74 |
| Met | 1 | 0.74 |
| Thr | 1 | 0.74 |
| Glu | 1 | 0.74 |
| total | 136 | 100% |
The optimal conditions for the hydrolysis of fish skin gelatin by different enzymes.
| Enzyme Type | Hydrolysis Conditions | Enzyme/Substrate ( | ||
|---|---|---|---|---|
| Optimum pH | Optimum Temperature (°C) | Hydrolysis Time (h) | ||
| pepsin | 2 | 37 | 4 | 0.05 |
| alkaline protease | 9 | 55 | 4 | 0.05 |
| bromelain | 6 | 55 | 4 | 0.05 |
| ginger protease | 6 | 55 | 4 | 0.05 |